Effects of denosumab versus teriparatide in glucocorticoid-induced osteoporosis patients with prior bisphosphonate treatment

INTRODUCTION: Osteoporosis is one of the serious adverse effects associated with glucocorticoid therapy. Although bisphosphonates have been used for glucocorticoid-induced osteoporosis (GIO), some patients have shown an inadequate response. In such cases, denosumab or teriparatide are used. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirooka, Yasuaki, Nozaki, Yuji, Inoue, Asuka, Li, Jinhai, Shiga, Toshihiko, Kishimoto, Kazuya, Sugiyama, Masafumi, Kinoshita, Koji, Funauchi, Masanori, Matsumura, Itaru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352055/
https://www.ncbi.nlm.nih.gov/pubmed/32676524
http://dx.doi.org/10.1016/j.bonr.2020.100293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352055/
https://www.ncbi.nlm.nih.gov/pubmed/32676524
http://dx.doi.org/10.1016/j.bonr.2020.100293

Ejemplares similares